Back
Teleflex, Inc. 10K Form
Sell
40
TFX
Teleflex, Inc.
Last Price:
$122.00
Seasonality Move:
4.48%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2023-11-03 | 10Q | TFX/Teleflex, Inc. Quarterly |
| 2023-08-03 | 10Q | TFX/Teleflex, Inc. Quarterly |
| 2023-05-04 | 10Q | TFX/Teleflex, Inc. Quarterly |
| 2022-10-27 | 10Q | TFX/Teleflex, Inc. Quarterly |
| 2022-07-28 | 10Q | TFX/Teleflex, Inc. Quarterly |
| 2022-04-28 | 10Q | TFX/Teleflex, Inc. Quarterly |
Receive TFX News And Ratings
See the #1 stock for the next 7 days that we like better than TFX
TFX Financial Statistics
Sales & Book Value
| Annual Sales: | $2B |
|---|---|
| Cash Flow: | $151.6M |
| Price / Cash Flow: | 22.22 |
| Annual Sales: | $64.83 |
| Price / Book: | 1.73 |
Profitability
| EPS (TTM): | -20.55700 |
|---|---|
| Net Income (TTM): | $-194.7M |
| Gross Margin: | $1.1B |
| Return on Equity: | -4.98% |
| Return on Assets: | -2.67% |
Teleflex, Inc. Earnings Forecast
Key Teleflex, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for TFX is 56.24%.
-
The Selling, General & Administrative Expenses for TFX have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 7.27% of Revenue.
-
The Interest Expense is 171.23% of Operating Income.
-
The Net Earning history of TFX is 2.94% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 26 years.
Teleflex, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | TFX |
| CUSIP: | 879369 |
| Website: | teleflex.com |
Debt
| Debt-to-Equity Ratio: | 0.87 |
|---|---|
| Current Ratio: | 2.54 |
| Quick Ratio: | 0.95 |
Price-to-Earnings
| Trailing P/E Ratio: | 80.45 |
|---|---|
| Forward P/E Ratio: | 8.34 |
TFX Technical Analysis vs Fundamental Analysis
Sell
40
Teleflex, Inc. (TFX)
is a Sell
Is Teleflex, Inc. a Buy or a Sell?
-
Teleflex, Inc. stock is rated a SellThe current Teleflex, Inc. [TFX] share price is $122.06. The Score for TFX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.